Validation of the Chinese version of the Head and Neck Patient Symptom Checklist for measuring nutrition impact symptoms during radiotherapy in patients with head and neck cancer

Sanli Jin,Qian Lu,Dong Pang,Yan Sun,Shaowen Xiao,Baomin Zheng,Hangjing Cui
DOI: https://doi.org/10.1007/s00520-019-04784-3
IF: 3.1
2019-01-01
Supportive Care in Cancer
Abstract:Purpose The Head and Neck Patient Symptom Checklist (HNSC) is a valid tool for measuring nutrition impact symptoms (NIS) specific to head and neck cancer (HNC) patients. This study aimed to translate the HNSC into Chinese and to evaluate its psychometric properties in Chinese HNC patients treated with radiotherapy. Methods The HNSC was translated into Chinese following standard forward- and back-translation procedures. Three instruments, the Chinese version of HNSC, the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30, and Patient-Generated Subjective Global Assessment (PG-SGA), were answered by 116 HNC patients, of whom 11 were submitted to the test–retest in 3–7 days. The criterion and convergent validities were confirmed by measuring the relations of the HNSC score with the PG-SGA and EORTC QLQ-C30, respectively. The discriminant validity was evaluated through known group analysis. Reliability was evaluated by means of Cronbach’s alpha and test–retest using the correlation coefficient. Results Criterion validity was 0.767 for intensity dimension and 0.795 for interference dimension, respectively. Convergent validity was confirmed by the significant correlations between the HHSC score and most domains of QLQ-C30. The comparison among the groups demonstrated good discriminant validity. The Cronbach’s alpha was 0.787 for intensity dimension and 0.797 for interference dimension, respectively. The test–retest reliability was 0.845 for intensity dimension and 0.883 for interference dimension, respectively. Conclusions The Chinese version of HNSC demonstrated favorable validity and reliability. It can be used in identification of NIS and development of symptom management program in HNC patients in China.
What problem does this paper attempt to address?